Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Hepatology (Baltimore, Md.)|April 29, 2009
Reactivation of hepatitis BJay H Hoofnagle
Hepatology (Baltimore, Md.)|October 31, 2002
Course and outcome of hepatitis CJay H Hoofnagle
The Journal of Clinical Investigation|August 5, 2003
Denying the wolf access to sheep's clothingTheo Heller, Jay H Hoofnagle
Clinics in Liver Disease|April 15, 2003
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002Leonard B Seeff, Jay H Hoofnagle
Nature|August 19, 2005
Mechanism of action of interferon and ribavirin in treatment of hepatitis CJordan J Feld, Jay H Hoofnagle
Hepatology (Baltimore, Md.)|October 31, 2015
Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reportsEinar S Björnsson, Jay H Hoofnagle
Hepatology (Baltimore, Md.)|October 31, 2002
Optimal therapy of hepatitis CAdrian M Di Bisceglie, Jay H Hoofnagle
Open Forum Infectious Diseases|March 16, 2022
Olfactomedin 4 Is a Biomarker for the Severity of Infectious DiseasesWenli Liu, Griffin P Rodgers
Biochimica Et Biophysica Acta. Reviews on Cancer|August 20, 2025
Olfactomedin 4 in cancer development and progressionWenli Liu, Griffin P Rodgers
Cancer Metastasis Reviews|May 15, 2016
Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancerWenli Liu, Griffin P Rodgers
Pageof 19